Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 24kWORD 21k
11 June 2019
E-001513/2019(ASW)
Answer given by Mr Andriukaitis on behalf of the European Commission
Question reference: E-001513/2019

1. Several pieces of EU legislation (concerning chemicals in general or specific products) aim to protect human health by identifying and minimising risks posed by exposure to chemicals. To this end, the Commission’s independent agencies and scientific committees(1) provide risk assessment on the exposure of citizens to chemicals and possible health effects.

The EU Research and Innovation Framework Programme supports research on a number of health issues, including the health impact of chemicals (also from mixtures) as well as on new methods and tools for risk assessment.

2. The European Centre for Disease Prevention and Control (ECDC) is responsible for communicable diseases; environmental related diseases are outside the mandate of the ECDC.

3. The World Health Organisation (WHO) with its members, including the EU Member States, is responsible for the revision of the International Classification of Diseases (ICD). The EU has observer-status in the WHO. The Commission does not have a mandate to promote the inclusion of any specific disease.

(1)https://ec.europa.eu/health/scientific_committees

Last updated: 13 June 2019Legal notice